News

Special Opportunities Fund Declares Cash Dividend for Shareholders

Special Opportunities Fund Declares Cash Dividend for Shareholders

Overview of the Special Opportunities Fund

Special Opportunities Fund, Inc. is an investment vehicle aimed at maximizing returns for its shareholders. Operating under the ticker NYSE: SPE, the Fund strategically invests in various securities to provide a diversified portfolio that aligns with investor goals.

Recent Dividend Announcement

Recently, the Fund's Board of Directors made a significant announcement regarding a cash dividend. The declared dividend stands at $0.171875 per share on the 2.75% Convertible Preferred Stock, Series C. Such dividends are vital as they signal the Fund's ongoing commitment to return value to its shareholders.

Payment Details for Shareholders

The dividend is scheduled to be paid on December 31, 2025, to all shareholders who are on record as of December 19, 2025. This timeline gives shareholders the chance to benefit from this financial decision while also reflecting the Fund's solid performance throughout the year.

Insights into Investment Strategy

The investment strategy employed by Special Opportunities Fund is designed to capitalize on market opportunities and ensure capital appreciation over time. By targeting a range of sectors, the Fund aims to mitigate risks while maximizing potential returns for investors.

Understanding Convertible Preferred Stock

Investing in convertible preferred stock provides unique advantages, such as the potential for capital gains and dividend payments. For many investors, such stocks represent a balanced investment approach, combining the stability of fixed income with the potential for growth.

How to Stay Informed

For current and prospective investors, staying informed about the Fund’s performance and key decisions is crucial. Regular updates from the Fund, including dividend announcements, serve as important indicators of its financial health and commitment to shareholder value.

Contact Information for Further Queries

If you have any inquiries regarding the Fund or its investment strategies, you can reach out to Thomas Antonucci at Bulldog Investors LLP at 1-201-566-0092. Clear communication helps shareholders understand the evolving landscape of their investments.

Frequently Asked Questions

What is the significance of the recent dividend declaration?

The dividend declaration signifies the Fund's commitment to shareholder returns and reflects its financial performance.

When will the dividend be paid?

The dividend is scheduled for payment on December 31, 2025.

How does the Fund decide on its dividend amounts?

Dividends are determined by the Board of Directors based on the Fund's earnings and investment strategy.

What is convertible preferred stock?

Convertible preferred stock offers dividends and the option to convert to common shares, combining benefits of both stock types.

How can investors stay updated on Fund news?

Investors can stay updated through official announcements and investor relations contacts such as Thomas Antonucci.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 26

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Twin Hospitality Group Prepares for Q3 2025 Financial Briefing

Updated Category News Views 114

Twin Hospitality Group Prepares for Q3 2025 Financial Briefing The anticipation is building as Twin Hospitality Group Inc. (NASDAQ: TWNP) prepares to host a conference call aimed at discussing their third quarter financial outcomes. On a date marked in the calendar, the company will unveil its results, allowing investors and analysts to gain insights into performance and...

Continue Reading
How FED Fitness and Talking Tom Are Reinventing Home Exercise

Updated Category News Views 238

FED Fitness and Talking Tom: A New Era in Home Workouts FED Fitness, a leading name in home fitness solutions, has joined forces with the popular character Talking Tom to create an exciting marketing campaign. This collaboration, titled “Sweat with Talking Tom. Fitness at Home,” aims to bring families together through fun, engaging exercise routines. Engaging Campaign...

Continue Reading
Revolutionizing Property Inspections with AI-Driven Solutions

Updated Category News Views 150

Revolutionizing Property Inspections with Advanced Technology In an era where technology shapes every industry, SnapInspect is at the forefront of innovation in property management. By integrating artificial intelligence into property inspection software, SnapInspect is revolutionizing the way inspections, reporting, and maintenance workflows are conducted. Setting New...

Continue Reading
American Industrial Partners Enhances Portfolio with AGCO Acquisition

Updated Category News Views 94

American Industrial Partners Acquires AGCO's Grain & Protein Division In a significant move to bolster its portfolio, American Industrial Partners (AIP) has finalized the acquisition of AGCO Corporation's grain and protein business. This newly formed company will be known as Grain & Protein Technologies and will be led by Jacob Thomas, a seasoned leader in the industrial...

Continue Reading
Marine Cabirou Shines with Bronze at 2025 Mountain Bike Worlds

Updated Category News Views 265

Marine Cabirou's Exciting Performance at World Championships Monster Energy is thrilled to announce that team rider Marine Cabirou, aged 28, earned a well-deserved bronze medal in the Downhill race at the 2025 UCI Mountain Bike World Championships. The event took place at the iconic Champéry bike park, where Cabirou demonstrated her exceptional skill against a backdrop...

Continue Reading